{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:56:39Z","timestamp":1782226599564,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["407476\/2016-4"],"award-info":[{"award-number":["407476\/2016-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro","doi-asserted-by":"publisher","award":["110.151\/2014"],"award-info":[{"award-number":["110.151\/2014"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.mvr.2018.07.005","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T12:31:52Z","timestamp":1532953912000},"page":"94-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Constitutive DPP4 activity, inflammation, and microvascular reactivity in subjects with excess body weight and without diabetes"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4414-6696","authenticated-orcid":false,"given":"Wellington Santana","family":"da Silva J\u00fanior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria das Gra\u00e7as Coelho de","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Firmino","family":"Nogueira Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliete","family":"Bouskela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3528-5881","authenticated-orcid":false,"given":"Luiz Guilherme","family":"Kraemer-Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mvr.2018.07.005_bb0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1748-1716.2011.02320.x","article-title":"Vasomotion - what is currently thought?","volume":"202","author":"Aalkjaer","year":"2011","journal-title":"Acta Physiol (Oxford)"},{"issue":"Suppl. 1","key":"10.1016\/j.mvr.2018.07.005_bb0010","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.thromres.2012.08.262","article-title":"Circulating biomarkers","volume":"130","author":"Badimon","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.mvr.2018.07.005_bb0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.atherosclerosis.2012.12.018","article-title":"Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors","volume":"227","author":"Barbieri","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mvr.2018.07.005_bb0020","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.physbeh.2011.12.004","article-title":"Novel findings in the cephalic phase of digestion: a role for microcirculation?","volume":"105","author":"Buss","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.mvr.2018.07.005_bb0025","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3233\/CH-168018","article-title":"Inflammation-induced microvascular dysfunction in obesity - a translational approach","volume":"64","author":"Souza","year":"2016","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.mvr.2018.07.005_bb0030","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1463-1326.2012.01603.x","article-title":"Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis","volume":"14","author":"Deacon","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.mvr.2018.07.005_bb0035","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc07-0228","article-title":"Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action","volume":"30","author":"Drucker","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mvr.2018.07.005_bb0040","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1210\/en.2012-1855","article-title":"Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice","volume":"154","author":"Ervinna","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.mvr.2018.07.005_bb0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vph.2011.05.001","article-title":"Cardiovascular effects of DPP-4 inhibition: beyond GLP-1","volume":"55","author":"Fadini","year":"2011","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.mvr.2018.07.005_bb0050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.mvr.2018.07.005_bb0055","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s11033-012-2361-x","article-title":"GLP-1-dependent and independent effects and molecular mechanisms of a dipeptidyl peptidase 4 inhibitor in vascular endothelial cells","volume":"40","author":"Hu","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.mvr.2018.07.005_bb0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mce.2015.01.025","article-title":"The dipeptidyl peptidase-IV inhibitor inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanisms","volume":"405","author":"Hwang","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mvr.2018.07.005_bb0065","first-page":"S33","article-title":"The myogenic response in the microcirculation and its interaction with other control systems","volume":"7","author":"Johnson","year":"1989","journal-title":"J. Hypertens. Suppl."},{"key":"10.1016\/j.mvr.2018.07.005_bb0070","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mvr.2006.05.006","article-title":"Low-frequency oscillations of the laser Doppler perfusion signal in human skin","volume":"72","author":"Kvandal","year":"2006","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.mvr.2018.07.005_bb0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/713609354","article-title":"Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV","volume":"40","author":"Lambeir","year":"2003","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.mvr.2018.07.005_bb0080","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/db10-1707","article-title":"Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome","volume":"60","author":"Lamers","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.mvr.2018.07.005_bb0085","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1210\/jc.2012-4288","article-title":"CD26\/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus","volume":"98","author":"Lee","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mvr.2018.07.005_bb0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.diabres.2006.10.005","article-title":"A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects","volume":"77","author":"Matsuhisa","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.mvr.2018.07.005_bb0095","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.2174\/092986709788803114","article-title":"Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme","volume":"16","author":"Matteucci","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.mvr.2018.07.005_bb0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.mvr.2018.07.005_bb0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2337\/dc15-0781","article-title":"Alogliptin, a dipeptidyl peptidase 4 inhibitor, prevents the progression of carotid atherosclerosis in patients with Type 2 Diabetes: the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)","volume":"39","author":"Mita","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mvr.2018.07.005_bb0110","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.biochi.2012.06.008","article-title":"Anti-inflammatory and anti-atherogenic properties of adiponectin","volume":"94","author":"Ohashi","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.mvr.2018.07.005_bb0115","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1464-5491.2010.03010.x","article-title":"Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions","volume":"27","author":"Pala","year":"2010","journal-title":"Diabet. Med."},{"key":"10.1016\/j.mvr.2018.07.005_bb0120","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2337\/dc12-0199","article-title":"Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition","volume":"35","author":"Rizzo","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mvr.2018.07.005_bb0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tips.2013.05.007","article-title":"Assessment of endothelial and neurovascular function in human skin microcirculation","volume":"34","author":"Roustit","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mvr.2018.07.005_bb0130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/eje.1.02221","article-title":"Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake","volume":"155","author":"Ryskjaer","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mvr.2018.07.005_bb0135","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJM198711263172202","article-title":"Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function?","volume":"317","author":"Sax","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2018.07.005_bb0140","first-page":"223","article-title":"Analysis of flow motion by the laser Doppler technique in patients with peripheral arterial occlusive disease","volume":"7","author":"Seifert","year":"1988","journal-title":"Int. J. Microcirc. Clin. Exp."},{"key":"10.1016\/j.mvr.2018.07.005_bb0145","doi-asserted-by":"crossref","first-page":"816164","DOI":"10.1155\/2015\/816164","article-title":"Dipeptidyl peptidase 4: a new link between diabetes mellitus and atherosclerosis?","volume":"2015","author":"Silva Junior","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"Suppl. 1","key":"10.1016\/j.mvr.2018.07.005_bb0150","first-page":"S11","volume":"36","author":"Standards of Medical Care in Diabetes\u20132013","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mvr.2018.07.005_bb0155","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-3083.2008.02029.x","article-title":"Soluble ICAM-1 and VCAM-1 as markers of endothelial activation","volume":"67","author":"Videm","year":"2008","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.mvr.2018.07.005_bb0160","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.bbadis.2014.06.004","article-title":"Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2","volume":"1842","author":"Wronkowitz","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mvr.2018.07.005_bb0165","doi-asserted-by":"crossref","first-page":"E2330","DOI":"10.1210\/jc.2014-1480","article-title":"Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and Metabolic Disorders Study","volume":"99","author":"Zheng","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286218301250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286218301250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T10:37:24Z","timestamp":1539599844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286218301250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":33,"alternative-id":["S0026286218301250"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2018.07.005","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Constitutive DPP4 activity, inflammation, and microvascular reactivity in subjects with excess body weight and without diabetes","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2018.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}